文献速递肝胆胰外科围术期管理与 ERAS

微创远端胰腺切除术较开放手术减少主要并发症的国际验证

International Validation of Reduced Major Morbidity After Minimally Invasive Distal Pancreatectomy Compared With Open Pancreatectomy.
PubMed 文献 · Ann Surg · 2021-01-01

该国际队列研究基于ACS-NSQIP数据(88中心,2014-2016)及荷兰胰腺癌组数据(17中心,2005-2016)外部验证,评估微创远端胰腺切除术(MIDP)与开放远端胰腺切除术(ODP)对30天复合主要并发症(CMM)的影响。结果显示MIDP独立关联CMM降低(OR 0.50,95%CI 0.42-0.60,P<0.001),外部验证确认(n=637,P<0.003)。MIDP实施率与术后并发症下降呈线性关系,观察中转率下CMM绝对风险降低11%(95%CI 7.3%-15%),中转率接近0%时改善至14%(95%CI 11%-18%)。

要点

  • MIDP与ODP相比,30天复合主要并发症风险显著降低(OR 0.50)。
  • MIDP实施率从0%升至100%,术后并发症下降呈线性关系。
  • 观察中转率下CMM绝对风险降低11%,中转率接近0%时可达14%。

核心结论

  • 国际研究预测MIDP较ODP可使全国范围CMM风险降低11%,且中转率降低时可能进一步改善。
  • 该发现证实了近期LEOPARD随机对照试验的次要结局。

研究设计与样本

  • 国际队列研究,使用ACS-NSQIP数据(88中心,2014-2016)和荷兰胰腺癌组数据(17中心,2005-2016)进行外部模型验证。
  • 纳入ACS-NSQIP患者2921例,其中MIDP 1562例(53%),中转率18%,ODP 1359例(47%)。
  • 采用多变量逻辑回归评估MIDP实施率(0%-100%)与中转率(0%-25%)对术后CMM的影响,使用估计边际效应。

主要发现

  • MIDP独立关联CMM降低(OR 0.50,95%CI 0.42-0.60,P<0.001),外部验证确认(n=637,P<0.003)。
  • MIDP实施率上升与术后并发症下降呈线性关系(从0%全ODP至100%全MIDP)。
  • 观察中转率下CMM绝对风险降低11%(95%CI 7.3%-15%),中转率接近0%时改善至14%(95%CI 11%-18%)。
  • 各亚组中观察到的效应相似。

临床怎么用

  • 在适宜患者中,MIDP可较ODP降低30天复合主要并发症风险。
  • 降低中转率可能进一步增加MIDP的绝对获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To quantify the nationwide impact of minimally invasive distal pancreatectomy (MIDP) on major morbidity as compared with open distal pancreatectomy (ODP). BACKGROUND: A recent randomized controlled trial (RCT) demonstrated significant reduction in time to functional recovery after MIDP compared with ODP, but was not powered to assess potential risk reductions in major morbidity. METHODS: International cohort study using the American College of Surgeons' National Quality Improvement Program (ACS-NSQIP) (88 centers; 2014-2016) to evaluate the association between surgical approach (MIDP vs ODP) and 30-day composite major morbidity (CMM; death or severe complications) with external model validation using Dutch Pancreatic Cancer Group data (17 centers; 2005-2016). Multivariable logistic regression assessed the impact of nationwide MIDP rates between 0% and 100% on postoperative CMM at conversion rates between 0% and 25%, using estimated marginal effects. A sensitivity analysis tested the impact at various scenarios and patient populations. RESULTS: Of 2921 ACS-NSQIP patients, 1562 (53%) underwent MIDP with 18% conversion, and 1359 (47%) underwent ODP. MIDP was independently associated with reduced CMM [odds ratio (OR) 0.50, 95% confidence interval (CI) 0.42-0.60, P < 0.001], confirmed by external model validation (n = 637, P < 0.003). The association between rising MIDP implementation rates and falling postoperative morbidity was linear between 0% (all ODP) and 100% (all MIDP). The absolute risk reduction for CMM was 11% (95% CI 7.3%-15%) at observed conversion rates and improved to 14% (95% CI 11%-18%) as conversion approached 0%. Similar effects were seen across subgroups. CONCLUSION: This international study predicted a nationwide 11% risk reduction for CMM after MIDP versus ODP, which is likely to improve as conversion rates decrease. These findings confirm secondary outcomes of the recent LEOPARD RCT.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Klompmaker S, de Rooij T, Koerkamp BG, et al. International Validation of Reduced Major Morbidity After Minimally Invasive Distal Pancreatectomy Compared With Open Pancreatectomy. Ann Surg. 2021. PMID: 31756173. doi:10.1097/SLA.0000000000003659

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。